Atrial fibrillation (AF) is a prevalent cardiac arrhythmia associated with significant thromboembolic and bleeding risks. The combined procedure of left atrial appendage closure (LAAC) and catheter ablation has emerged as an innovative approach to address these dual challenges, particularly in high-risk patients. This review explores the evolution of LAAC, highlights clinical evidence supporting its integration with catheter ablation, and discusses technological advancements shaping its future. Studies demonstrate that the combined procedure significantly reduces stroke and bleeding risks, achieves high procedural success rates, and ensures effective arrhythmia control. Real-world data further validate its safety and efficacy, particularly in specialized centers. Despite its promise, challenges such as residual leaks, procedural complexity, and the need for standardized protocols persist. Emerging technologies, including personalized device designs and artificial intelligence, hold the potential to optimize outcomes and expand accessibility. The combined procedure represents a transformative strategy in AF management, offering a holistic solution for improving patient outcomes while minimizing risks.